Genetic heterogeneity of swine hepatitis E virus isolates from Yunnan province, China in 2011–2012
- Xianghua Shu†1,
- Xinhui Duan†1,
- Chunlian Song1,
- Jintao Li2,
- Lei Jiang1,
- Gefen Yin1 and
- Wengui Li1Email author
© Shu et al.; licensee BioMed Central Ltd. 2014
Received: 26 March 2014
Accepted: 28 August 2014
Published: 4 September 2014
Hepatitis E is a disease of major public-health concern mainly in developing countries. Although molecular and sero-epidemiological investigations of HEV have been performed in many provinces in China, the epidemiological data from Yunnan Province are limited and genotypes are not be fully characterized. In this study the prevalence and characteristics of hepatitis E virus (HEV) detected in pigs from Yunnan province, China was evaluated.
A total of 13 out of 187 pig fecal samples collected in 2011 revealed HEV positive results; likewise, 7 out of 69 samples collected in 2012 exhibited positive results. These findings indicated a total prevalence of 7.8% (20/256). Phylogenetic and molecular evolutionary analysis results revealed that nine strains were found in the samples obtained in 2011, in which 87.1% to 99.4% nucleotide sequence identity was shared among these strains; and 77.0% to 81.9%, 52.2% to 53.6%, 77.0% to 88.2% and 77.9% to 96.8% nucleotide sequence identities were shared with strains representing genotypes 1, 2, 3, and 4. Five strains were detected in the samples obtained in 2012, in which 94.2% to 99.3% nucleotide sequence identity was shared among the strains, and 81.0% to 82.5%, 81.8% to 83.2%, 81.0% to 92.7% and 81.0% to 97.8% nucleotide sequence identities were shared with strains representing the genotypes 1, 2, 3, and 4.
Analysis of fourteen detected HEV strains revealed that three of them were subtype 4d, two were subtype 4b; the nine remaining isolated strains were subtype 4 h. These results indicated that the prevalence of HEV in the swine herds of Yunnan was quite high, additional public-health concerns should focus on pork safety.
KeywordsHepatitis E virus Phylogenetic analysis Viral diversity
Hepatitis E, caused by hepatitis E virus (HEV), is the most frequent cause of acute hepatitis, acute liver failure, and acute-to-chronic liver failure in humans. Hepatitis E causes high morbidity and mortality in patients with underlying liver disease; this disease can also progress into chronic infection that causes fibrosis in immunocompromised hosts . Based on seroprevalence data the World Health Organization (WHO) estimated that at least one-third of the world population, residing mainly in Asia, Africa, Middle East, and Central America exhibits history of HEV infection .
HEV is the sole member of the genus Hepevirus in the family Hepeviridae. The genome is a single-stranded, positive-sense RNA molecule of approximately 7.2 kb in size. HEV is genetically diverse, although all of the mammalian HEV isolates possibly belong to a single serotype. The known HEV sequences have been analyzed, revealing at least four major genotypes (genotypes 1 to 4). G1 and G2 are transmitted from one human to another, and these genotypes are often associated with outbreaks or large epidemics in developing countries; G3 and G4 are zoonotic, in which swine and other animals function as reservoir of human HEV infections. With the identification of infectious HEV in meat and meat products and resultant sporadic cases of food-borne hepatitis E in human populations, food safety associated with HEV contamination has been considered as an important public health concern [3, 4], particularly in developing countries where sporadic cases have been increasingly documented .
Although molecular and sero-epidemiological investigations of HEV have been performed in many provinces in China, the epidemiological data from Yunnan Province are limited; genotypes are yet to be fully characterized. The study aimed to investigate the prevalence of HEV infection among pigs and determine the extent of genetic variations in Yunnan HEV strains by phylogenetic and molecular evolutionary analyses.
Among the 187 fecal samples collected in 2011, 13 (7.0%) were positive for HEV RNA after RT-nPCR detection was performed; among the 69 samples collected in 2012, 7 (10.1%) positive samples were found. All of the 20 products were sequenced and aligned. Five of the thirteen strains detected in 2011 and three of the seven strains detected in 2012 shared identical sequences but were removed. Fourteen sequences were identified in this study. Nine sequences detected in 2011 were deposited in GenBank: YN11-1 (JN542514), YN11-2 (JN542515), YN11-3 (JN542516), swYN11-4 (JN613152), swYN11-5 (JN613153), swYN11-6 (JN613154), swYN11-7 (JN613155), swYN11-8 (JN613156), and swYN11-9 (KF703731). Five sequences (swKM12-2, swKM12-3, swKM12-4, swKM12-5, and swKM12-6) detected in 2012 were unacceptable in GenBank because these sequences were < 200 bp in length (Additional file 1).
Phylogenetic analysis of PCR products
Genotype and subgenotype analyses
Our results revealed that all of the 14 isolates belonged to G4 HEV and clustered with China swine and human HEV sequences. Subtype analysis results revealed that most of the sequences (71.4%, 9/14) were subtyped as 4 h, three (swYN12-3, swYN12-5, and swYN12-6) were subtyped as 4d and two (YN11-2, and swYN11-4) were subtyped as 4b. Phylogenetic analysis results showed that a distinct G4 lineage (4 h) is circulating in Yunnan Province. Amino acid analysis results revealed unique mutations of F3 → L3, R34 → C34, S46 → P46, D77 → G77, and G87 → S87 in nine strains detected in 2011 and P21 → S21, A24 → T24, and V27 → A27 in five strains detected in 2012.
Various HEV genotypes exhibit different modes of transmission, non-human reservoirs, and abilities of interspecies transmission, although HEV is mainly transmitted in water and food. G3 and G4 are known as causative agents of zoonotic diseases; thus researchers have been prompted to determine the reason that G3 and G4 can cross species barriers, but G1 and G2 strains cannot . G3 HEV is mainly prevalent in humans of certain industrialized nations and has also been isolated from domestic and wild swine, deer, mongoose, rats, and rabbits. Whereas, G4 HEV is associated with sporadic cases of hepatitis E in humans and infects both wild and domestic swine; G4 HEV is also reportedly detected in cattle and sheep [3, 7]. Previous studies have suggested that the zoonotic transmission of HEV across several species, such as humans, pigs, boars, deer, chickens, and rabbits, may be the major mode of infection in non-endemic areas. Contact with swine is the most widely recognized route of occupational exposure to HEV, and humans have been considered as a major source of HEV in endemic areas [8, 9]. Epidemiological patterns also differ significantly between regions where this disease is highly endemic. A recent study in China even found that the seasonal changes in the prevalence of HEV in swine may be attributed to the geographical distribution of different subtypes .
Studies have been conducted regarding HEV transmission in non-human primates such as cynomolgus, rhesus, owl monkeys, and chimpanzees, as well as in pigs, rabbits, and Mongolian gerbils . Experimental HEV infections in animal models have provided relevant information regarding the biological characteristics and pathogenesis of HEV; these animal models are also essential tools used in vaccine and drug test . However, effective tissue culture replication systems of HEV have rarely been developed . Furthermore, the pathogenesis of liver pathology and the replication cycle of HEV remain poorly understood because cultured cells are unable to propagate efficiently in vitro.
G4 is responsible for the majority of sporadic hepatitis E cases affecting humans in China, and the high prevalence of G4 in pig population exacerbates this situation. G4-induced disease symptoms are possibly more severe than other types. In a previous study involving putative HEV G4 virulence determinants, one potential determinant is located in each of the 5ʹ-UTR and 3ʹ-UTR, 3 and 12 determinants are detected in ORF1 and ORF2, respectively, and two determinants are found in the junction . Thus far, at least nine subtypes (4a–4i) of G4 HEV isolates have been identified; numerous new subgenotypes have been reported in humans and pigs [15–18]. In one of our previous surveys, at least four subgenotypes (4c, 4d, 4b, and a new subgenotype) are prevalent in Yunnan Province. Five of the nine known subgenotypes of G4 have been identified as prevalent in Yunnan Province. Furthermore, subtype 4 h is dominant and has been isolated from a human patient with liver failure in south of China .
The lack of a standardized assay for clinical diagnosis remains a challenging issue, thus HEV has been considered as an underreported pathogen of acute hepatitis cases. The diagnosis of HEV infection should depend on RT-PCR and serology. The majority of HEV RT-PCR assays used for diagnosis have been developed by choosing different conserved HEV genomic regions as a target for amplification and primers and probes should also be designed to guarantee the development of highly sensitive and broadly reactive assays because of the wide genetic heterogeneity of the HEV genome . In general, G4 exhibits the lowest nucleotide sequence identity with G2 but higher nucleotide sequence identity in the same genotype. At present, HEV infections are serologically diagnosed by ELISA. The recombinant human HEV capsid antigen undergoes cross-reaction with antibodies to swine HEV in ELISA and has been widely used to detect anti-HEV antibody in swine .
A majority of infections in animals are asymptomatic and have not caused any economic loss in pig farms. As a result, the high prevalence of HEV in swine population cannot attract active management from farmers or authorities. Previous study results indicated that sustained transmission could induce changes in virulence; as such, severe consequences may occur . Meanwhile, the number of published HEV sequences has increased significantly, analysis of genomic sequences of multiple HEV isolates have revealed extensive genomic diversity. Since the development of the first vaccine to prevent hepatitis E infection of humans registered in China in 2011, an effective method to control hepatitis E has been established. Nevertheless, HEV infection should also be controlled in reservoir animals, particularly in swine. Further studies should also be conducted to determine the duration of protection from vaccination, zoonotic transfer mode, difference in virulence between genotype and subgenotype, and vaccine for host animals.
G4 HEV is highly prevalence in Yunnan Province of China and 4 h is likely the predominant subtype. Authorities should raise public-health concerns related to pork safety and risk of HEV infection via the consumption of undercooked pork products.
Materials and methods
Sampling sites and HEV detection results
No. of samples
Luquan County (piglet market)
JiangChuan County (back yard)
Fumin County (back yard)
Fumin County (piglet market)
Shilin County (pig Farms)
RNA extraction and reverse transcription-nested PCR
To detect HEV infection by reverse transcriptase nest polymerase chain reaction (RT-nPCR), we used nested universal primers, forming 348 bp products . In 2012, the prevalence of HEV strains in 2011 was significantly divergent; as such, the primers used were replaced with more sensitive primers that can amplify all of the known HEV sequences at that time . Total RNA was extracted from 100 μl of stool suspension according to the manufacturer’s instructions. RT-nPCR was then performed according to previously described methods .
Sequencing and phylogenetic analysis
Reference HEV sequences used in the phylogenetic analyses
This study was supported by a grant from the National Natural Science Foundation of China (Grant No. 31160495).
- Sclair SN, Schiff ER: An update on the hepatitis E virus. Curr Gastroenterol Rep 2013, 15: 304.PubMedView Article
- Shouval D: Focus. What is the significance of hepatitis E as a public health threat in the industrialized countries? Hepatitis E virus infection in Italy. J Hepatol 2011, 54: 1-2.PubMedView Article
- Feagins AR, Opriessnig T, Guenette DK, Halbur PG, Meng XJ: Detection and characterization of infectious Hepatitis E virus from commercial pig livers sold in local grocery stores in the USA. J Gen Virol 2007, 88: 912-917. 10.1099/vir.0.82613-0PubMedView Article
- Li TC, Chijiwa K, Sera N, Ishibashi T, Etoh Y, Shinohara Y, Kurata Y, Ishida M, Sakamoto S, Takeda N, Miyamura T: Hepatitis E virus transmission from wild boar meat. Emerg Infect Dis 2005, 11: 1958-1960. 10.3201/eid1112.051041PubMedPubMed CentralView Article
- Aggarwal R, Jameel S: Hepatitis E vaccine. Hepatol Int 2008, 2: 308-315. 10.1007/s12072-008-9071-4PubMedPubMed CentralView Article
- Yang D, Jiang M, Jin M, Qiu Z, Cui W, Shen Z, Li B, Gong L, Chen Z, Wang X, Li JW: Full-length sequence analysis of hepatitis E virus isolates: showing potential determinants of virus genotype and identity. Virus Genes 2013, 47: 414-421. 10.1007/s11262-013-0962-7PubMedView Article
- Yugo DM, Meng XJ: Hepatitis E virus: foodborne, waterborne and zoonotic transmission. Int J Environ Res Public Health 2013, 10: 4507-4533. 10.3390/ijerph10104507PubMedPubMed CentralView Article
- Huang FF, Haqshenas G, Guenette DK, Halbur PG, Schommer SK, Pierson FW, Toth TE, Meng XJ: Detection by reverse transcription-PCR and genetic characterization of field isolates of swine hepatitis E virus from pigs in different geographic regions of the united states. J Clin Microbiol 2002, 40: 1326-1332. 10.1128/JCM.40.4.1326-1332.2002PubMedPubMed CentralView Article
- Inoue J, Takahashi M, Yazaki Y, Tsuda F, Okamoto H: Development and validation of an improved RT-PCR assay with nested universal primers for detection of hepatitis E virus strains with significant sequence divergence. J Virol Methods 2006, 137: 325-333. 10.1016/j.jviromet.2006.07.004PubMedView Article
- Meng XJ: Hepatitis E virus: animal reservoirs and zoonotic risk. Vet Microbiol 2010, 140: 256-265. 10.1016/j.vetmic.2009.03.017PubMedPubMed CentralView Article
- Li W, She R, Wei H, Zhao J, Wang Y, Sun Q, Zhang Y, Wang D, Li R: Prevalence of hepatitis E virus in swine under different breeding environment and abattoir in Beijing, China. Vet Microbiol 2009, 133: 75-83. 10.1016/j.vetmic.2008.06.026PubMedView Article
- Erker JC, Desai SM, Mushahwar IK: Rapid detection of Hepatitis E virus RNA by reverse transcription-polymerase chain reaction using universal oligonucleotide primers. J Virol Meth 1999, 81: 109-113. 10.1016/S0166-0934(99)00052-XView Article
- Holla RP, Ahmad I, Ahmad Z, Jameel S: Molecular virology of hepatitis E virus. Semin Liver Dis 2013, 33: 3-14. 10.1055/s-0033-1338110PubMedView Article
- Zhu Y, Yu X, Huang F, Yu R, Dong S, Si F, Zhang Y, Li Z: Determination of the full-genome sequence of hepatitis E virus (HEV) SAAS-FX17 and use as a reference to identify putative HEV genotype 4 virulence determinants. Virol J 2012, 9: 264. 10.1186/1743-422X-9-264PubMedPubMed CentralView Article
- Geng Y, Zhao C, Fan J, Harrison TJ, Zhang H, Lian H, Geng K, Wang Y: Genotype analysis of hepatitis E virus from sporadic hepatitis E cases in northern China. Infect Genet Evol 2013, 20: 413-417.PubMedView Article
- Ren H, Li YT, Zhou X, Wang Y, Zheng YJ, Zhu YY, Lu YH: Epidemiologic and genetic characteristics of hepatitis E virus in Shanghai, 1997-2012. Zhonghua Liu Xing Bing Xue Za Zhi 2013, 34: 419-423.PubMed
- Dai X, Dong C, Zhou Z, Liang J, Dong M, Yang Y, Fu J, Tian H, Wang S, Fan J, Meng J, Purdy M: Hepatitis E virus genotype 4, Nanjing, China, 2001-2011. Emerg Infect Dis 2013, 19: 1528-1530. 10.3201/eid1909.130013PubMedPubMed CentralView Article
- Jinshan J, Manglai D, Takahashi M, Nagashima S, Okamoto H: Molecular and serological survey of hepatitis E virus infection among domestic pigs in Inner Mongolia, China. Arch Virol 2010, 155: 1217-1226. 10.1007/s00705-010-0706-0PubMedView Article
- Bu Q, Wang X, Wang L, Liu P, Geng J, Wang M, Han J, Zhu Y, Zhuang H: Hepatitis E virus genotype 4 isolated from a patient with liver failure: full-length sequence analysis showing potential determinants of virus pathogenesis. Arch Virol 2013, 158: 165-172. 10.1007/s00705-012-1488-3PubMedView Article
- Pelosi E, Clarke I: Hepatitis E: a complex and global disease. Emerg Health Threats J 2008, 1: e8.PubMedPubMed Central
- Aggarwal R: Hepatitis E virus and person-to-person transmission. Clin Infect Dis 2010, 51: 477-478.PubMedView Article
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.